The Cancer Registry as facilitator for the healthcare industry
The Cancer Registry of Norway shall promote and provide a basis for research on cancer diagnosis, causes, natural progress and treatment effects. Facilitating the healthcare industry's use of the data managed by the Cancer Registry of Norway is therefore important.
We facilitates by making data and information available via various channels.
Part of the health industry's interest concerns treatment with drugs and diagnostics using molecular markers. In order to increase the quality (e.g. the completeness of data on drug use), we have initiated the project INSPIRE, in collaboration with industry and other participants.
In addition to making data available through various channels, the Cancer Registry of Norway collaborates with the healthcare industry on specific research projects, both in the form of commissioned research and contributory research. Some of the researchers also contribute to projects run under the auspices of the healthcare industry.
Ongoing projects with the health industry
Completed projects with the health industry
|LTFU1 (Long-term follow-up of participants vaccinated with the HPV vaccine Gardasil)
|Thea E. Hetland Falkenthal
|Does Gardasil cause birth defects?
|Registry study of patients with lung cancer i.e. use of tyrosine, kinase inhibitors and EGFR mutation status
|Tom Børge Johannesen
Guidelines for collaboration
The Cancer Registry's cooperation with the health industry is subject to several collaboration agreements and guidelines, and in all forms of cooperation we apply principles of openness, transparency and professional integrity for our researchers and other employees.
- Cooperation agreement between Helse Sør-Øst RHF (the health region) and the pharmaceutical industry (LMI).
- Collaboration agreement between Helse Sør-Øst (the health region) and LFH – the trade association for health and welfare technology.
- Guideline OUS "Cooperation with industry".
- Guideline OUS "Cooperation with industry in research, innovation and development projects".
*Agreements on commissioned and contributory research are made by Inven2 on behalf of the Cancer Registry of Norway/OUS.